Ciprian Catana, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 88 | 2024 | 6413 | 6.680 |
Why?
|
Magnetic Resonance Imaging | 78 | 2024 | 35932 | 2.570 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2022 | 8933 | 2.070 |
Why?
|
Whole Body Imaging | 9 | 2022 | 278 | 1.870 |
Why?
|
Dopamine | 5 | 2022 | 1578 | 1.080 |
Why?
|
Fluorodeoxyglucose F18 | 18 | 2024 | 1993 | 1.070 |
Why?
|
Brain | 35 | 2024 | 26659 | 0.980 |
Why?
|
Movement | 4 | 2018 | 1469 | 0.970 |
Why?
|
Receptors, GABA | 10 | 2024 | 310 | 0.890 |
Why?
|
Abdomen | 4 | 2018 | 1112 | 0.830 |
Why?
|
Phantoms, Imaging | 14 | 2023 | 2486 | 0.760 |
Why?
|
Collagen Type I | 3 | 2023 | 587 | 0.750 |
Why?
|
Molecular Imaging | 5 | 2023 | 826 | 0.700 |
Why?
|
Radiopharmaceuticals | 15 | 2021 | 2652 | 0.650 |
Why?
|
Systems Integration | 3 | 2016 | 427 | 0.630 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 75 | 0.590 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20351 | 0.590 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 285 | 0.550 |
Why?
|
Equipment Design | 6 | 2019 | 3511 | 0.540 |
Why?
|
Artifacts | 7 | 2020 | 1891 | 0.530 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 291 | 0.480 |
Why?
|
Algorithms | 18 | 2022 | 13897 | 0.470 |
Why?
|
Neuroglia | 5 | 2018 | 940 | 0.460 |
Why?
|
Gallium Radioisotopes | 4 | 2023 | 178 | 0.460 |
Why?
|
Nuclear Medicine | 3 | 2023 | 234 | 0.460 |
Why?
|
Respiration | 3 | 2018 | 1646 | 0.450 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 490 | 0.440 |
Why?
|
Fibrin | 6 | 2021 | 504 | 0.440 |
Why?
|
Receptors, Dopamine D2 | 5 | 2022 | 482 | 0.430 |
Why?
|
Metals | 1 | 2017 | 726 | 0.410 |
Why?
|
Acoustics | 1 | 2013 | 242 | 0.390 |
Why?
|
Head | 2 | 2019 | 911 | 0.390 |
Why?
|
Glioblastoma | 5 | 2019 | 3471 | 0.370 |
Why?
|
Raclopride | 5 | 2022 | 101 | 0.350 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1272 | 0.350 |
Why?
|
Image Enhancement | 4 | 2017 | 2890 | 0.340 |
Why?
|
Memory, Short-Term | 1 | 2016 | 963 | 0.340 |
Why?
|
Motion | 4 | 2019 | 782 | 0.340 |
Why?
|
Contrast Media | 7 | 2019 | 5285 | 0.330 |
Why?
|
Humans | 88 | 2024 | 752411 | 0.290 |
Why?
|
Corpus Striatum | 3 | 2022 | 1220 | 0.290 |
Why?
|
Nerve Net | 2 | 2016 | 2194 | 0.280 |
Why?
|
Dementia | 2 | 2018 | 2585 | 0.270 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 145 | 0.270 |
Why?
|
Brain Mapping | 9 | 2018 | 6521 | 0.270 |
Why?
|
Receptors, Dopamine D3 | 3 | 2017 | 106 | 0.260 |
Why?
|
Transducers | 1 | 2006 | 235 | 0.250 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2019 | 1676 | 0.250 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2022 | 2767 | 0.250 |
Why?
|
Copper Radioisotopes | 2 | 2015 | 90 | 0.250 |
Why?
|
Neurology | 1 | 2012 | 762 | 0.240 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5697 | 0.230 |
Why?
|
Subtraction Technique | 1 | 2006 | 519 | 0.220 |
Why?
|
Meninges | 1 | 2024 | 196 | 0.210 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2018 | 1436 | 0.200 |
Why?
|
Acetamides | 3 | 2024 | 256 | 0.190 |
Why?
|
BCG Vaccine | 1 | 2024 | 366 | 0.190 |
Why?
|
Reproducibility of Results | 11 | 2022 | 19901 | 0.190 |
Why?
|
Male | 48 | 2024 | 354908 | 0.190 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 109 | 0.180 |
Why?
|
Adult | 31 | 2024 | 216927 | 0.170 |
Why?
|
Monte Carlo Method | 2 | 2016 | 1267 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1085 | 0.170 |
Why?
|
Echo-Planar Imaging | 2 | 2022 | 656 | 0.170 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2024 | 243 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 423 | 0.160 |
Why?
|
Yttrium Radioisotopes | 1 | 2019 | 107 | 0.160 |
Why?
|
Nucleus Accumbens | 2 | 2022 | 362 | 0.160 |
Why?
|
Chicago | 1 | 2019 | 242 | 0.160 |
Why?
|
Thrombosis | 4 | 2021 | 3018 | 0.160 |
Why?
|
Papio | 2 | 2017 | 663 | 0.160 |
Why?
|
Expert Testimony | 1 | 2021 | 361 | 0.150 |
Why?
|
Thalamus | 2 | 2014 | 1016 | 0.150 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 14588 | 0.150 |
Why?
|
Spleen | 1 | 2024 | 2274 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 8 | 0.150 |
Why?
|
Stilbenes | 1 | 2018 | 154 | 0.150 |
Why?
|
Drug Partial Agonism | 1 | 2017 | 24 | 0.150 |
Why?
|
Capillary Permeability | 2 | 2019 | 768 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 42 | 0.150 |
Why?
|
Middle Aged | 28 | 2024 | 217039 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 291 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 647 | 0.150 |
Why?
|
Normal Distribution | 1 | 2018 | 271 | 0.150 |
Why?
|
Skull | 3 | 2019 | 812 | 0.150 |
Why?
|
Female | 40 | 2024 | 386085 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9449 | 0.140 |
Why?
|
Head Movements | 1 | 2018 | 152 | 0.140 |
Why?
|
Pelvis | 1 | 2021 | 736 | 0.140 |
Why?
|
Gadolinium | 2 | 2019 | 948 | 0.140 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2024 | 538 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2021 | 3755 | 0.140 |
Why?
|
Heart | 2 | 2020 | 4377 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1180 | 0.130 |
Why?
|
Brain Neoplasms | 4 | 2019 | 8892 | 0.130 |
Why?
|
Quinpirole | 1 | 2015 | 32 | 0.130 |
Why?
|
Venous Thrombosis | 2 | 2015 | 1278 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 264 | 0.130 |
Why?
|
Blood Glucose | 2 | 2024 | 6331 | 0.130 |
Why?
|
Dopamine Agonists | 2 | 2015 | 349 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2022 | 1015 | 0.130 |
Why?
|
Aged | 21 | 2024 | 166585 | 0.130 |
Why?
|
Starvation | 1 | 2015 | 140 | 0.120 |
Why?
|
Hip | 1 | 2016 | 249 | 0.120 |
Why?
|
Radiometry | 2 | 2022 | 816 | 0.120 |
Why?
|
Photons | 2 | 2016 | 588 | 0.120 |
Why?
|
Medical Oncology | 2 | 2019 | 2283 | 0.120 |
Why?
|
Workflow | 1 | 2019 | 841 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 545 | 0.120 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 599 | 0.120 |
Why?
|
Object Attachment | 1 | 2017 | 321 | 0.110 |
Why?
|
Animals | 25 | 2024 | 166811 | 0.110 |
Why?
|
Fibromyalgia | 1 | 2018 | 397 | 0.110 |
Why?
|
Placebo Effect | 1 | 2017 | 510 | 0.110 |
Why?
|
Low Back Pain | 1 | 2022 | 966 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2018 | 1056 | 0.110 |
Why?
|
Analgesia | 1 | 2017 | 449 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3327 | 0.110 |
Why?
|
Unconsciousness | 1 | 2014 | 219 | 0.110 |
Why?
|
Mother-Child Relations | 1 | 2017 | 488 | 0.110 |
Why?
|
Signal Transduction | 1 | 2016 | 23234 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.110 |
Why?
|
Sensory Receptor Cells | 1 | 2017 | 501 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 846 | 0.100 |
Why?
|
Bone and Bones | 2 | 2014 | 2551 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 806 | 0.100 |
Why?
|
Motor Neurons | 1 | 2016 | 849 | 0.100 |
Why?
|
Carbon Radioisotopes | 3 | 2018 | 581 | 0.100 |
Why?
|
Pyridines | 3 | 2024 | 2862 | 0.100 |
Why?
|
Thermogenesis | 1 | 2015 | 467 | 0.090 |
Why?
|
Models, Neurological | 3 | 2015 | 1738 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11063 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1501 | 0.090 |
Why?
|
Pyrimidines | 3 | 2018 | 2979 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1065 | 0.090 |
Why?
|
Basal Ganglia | 1 | 2013 | 549 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2015 | 862 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3374 | 0.090 |
Why?
|
Cerebrovascular Circulation | 2 | 2017 | 2708 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3830 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2011 | 490 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3141 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 57632 | 0.080 |
Why?
|
Motor Cortex | 1 | 2016 | 978 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58299 | 0.080 |
Why?
|
Dopamine Antagonists | 3 | 2015 | 289 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1286 | 0.080 |
Why?
|
Kinetics | 2 | 2013 | 6352 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2016 | 1373 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1645 | 0.080 |
Why?
|
Protons | 2 | 2018 | 1120 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2016 | 1377 | 0.080 |
Why?
|
Macaca mulatta | 4 | 2017 | 2306 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2248 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2016 | 2280 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2053 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4171 | 0.080 |
Why?
|
Pair Bond | 1 | 2007 | 9 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2015 | 1246 | 0.080 |
Why?
|
Quinazolines | 2 | 2011 | 1355 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1355 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 662 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 39846 | 0.070 |
Why?
|
Brain Injuries | 1 | 2019 | 1967 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2017 | 2186 | 0.070 |
Why?
|
Pilot Projects | 2 | 2024 | 8443 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4898 | 0.070 |
Why?
|
Visual Perception | 1 | 2014 | 1368 | 0.070 |
Why?
|
Receptors, Opioid | 2 | 2017 | 145 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4271 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2022 | 2285 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1665 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8511 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16443 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2006 | 846 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 21851 | 0.060 |
Why?
|
Neural Pathways | 1 | 2014 | 2986 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1067 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3313 | 0.060 |
Why?
|
Pain | 2 | 2018 | 4989 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9207 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2019 | 5148 | 0.050 |
Why?
|
Radio Waves | 1 | 2023 | 250 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 259 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2019 | 2906 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2515 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 86766 | 0.050 |
Why?
|
Rabbits | 2 | 2021 | 4761 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2017 | 20840 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10696 | 0.050 |
Why?
|
Mice | 8 | 2024 | 80550 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2014 | 3970 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6112 | 0.040 |
Why?
|
Lung | 2 | 2023 | 9898 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1978 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 91 | 0.040 |
Why?
|
Technology, Radiologic | 1 | 2019 | 160 | 0.040 |
Why?
|
Afghanistan | 1 | 2019 | 78 | 0.040 |
Why?
|
Iraq | 1 | 2019 | 94 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 623 | 0.040 |
Why?
|
Air | 1 | 2019 | 184 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11587 | 0.040 |
Why?
|
Computer Security | 1 | 2020 | 261 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4341 | 0.040 |
Why?
|
Computers | 1 | 2020 | 596 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2013 | 1540 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2017 | 35 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11265 | 0.040 |
Why?
|
Rats | 4 | 2015 | 23563 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2021 | 950 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6792 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 21806 | 0.040 |
Why?
|
Biomedical Research | 1 | 2012 | 3379 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8582 | 0.040 |
Why?
|
Organometallic Compounds | 2 | 2010 | 658 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1127 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 176 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2017 | 460 | 0.030 |
Why?
|
Prochlorperazine | 1 | 2015 | 16 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3395 | 0.030 |
Why?
|
Spin Labels | 1 | 2017 | 335 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15143 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2017 | 598 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1380 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2627 | 0.030 |
Why?
|
Behavior, Animal | 2 | 2017 | 1854 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 843 | 0.030 |
Why?
|
Blast Injuries | 1 | 2019 | 321 | 0.030 |
Why?
|
Diprenorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 631 | 0.030 |
Why?
|
Myocardium | 2 | 2022 | 4652 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5594 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10796 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2015 | 8157 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 79133 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 594 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2613 | 0.030 |
Why?
|
Computer Simulation | 2 | 2017 | 6166 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15622 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1665 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29337 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 394 | 0.030 |
Why?
|
Hypercapnia | 1 | 2014 | 261 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1114 | 0.030 |
Why?
|
Benzamides | 1 | 2017 | 1364 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 371 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 756 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2387 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 40980 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1318 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3034 | 0.020 |
Why?
|
Dexmedetomidine | 1 | 2014 | 313 | 0.020 |
Why?
|
Fluorine | 1 | 2010 | 84 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1632 | 0.020 |
Why?
|
Reward | 1 | 2017 | 945 | 0.020 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2010 | 65 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 452 | 0.020 |
Why?
|
Microglia | 1 | 2018 | 1322 | 0.020 |
Why?
|
Military Personnel | 1 | 2019 | 1143 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 568 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1112 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 249 | 0.020 |
Why?
|
Software | 2 | 2016 | 4420 | 0.020 |
Why?
|
Fasting | 1 | 2015 | 1590 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1865 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 1838 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 810 | 0.020 |
Why?
|
Extracellular Space | 1 | 2011 | 565 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2181 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1478 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3065 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2347 | 0.020 |
Why?
|
Pitheciidae | 1 | 2007 | 2 | 0.020 |
Why?
|
Models, Chemical | 1 | 2010 | 611 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1202 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3463 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1815 | 0.020 |
Why?
|
Glucose | 2 | 2010 | 4343 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2483 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 25539 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2373 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6955 | 0.020 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 417 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1893 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2509 | 0.020 |
Why?
|
Veterans | 1 | 2019 | 2571 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3196 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2008 | 4035 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2015 | 17958 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2176 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5045 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16737 | 0.010 |
Why?
|
Child | 1 | 2010 | 79004 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11008 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2036 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15680 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12869 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1795 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6047 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6234 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4292 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3502 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 2500 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15647 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39077 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10360 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35675 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12138 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 21717 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 53809 | 0.000 |
Why?
|